Sarah Hrebien
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 22
- Oncology top 2%
- Lung Cancer Research Studies 6
- Cancer Cells and Metastasis 6
-
- Advanced Breast Cancer Therapies 9
- Lung Cancer Treatments and Mutations 3
-
- Genetic factors in colorectal cancer 7
- Genetics top 5%
-
- Molecular Biology Techniques and Applications 4
- Single-cell and spatial transcriptomics 2
- Co-authors
- Nicholas C. TurnerIsaac García-MurillasRosalind CuttsBen O’LearyMitch DowsettMassimo CristofanilliCynthia Huang BartlettGaia Schiavon
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Sarah Hrebien
26 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Cancer Research 2.1k
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.6k
- Pathology and Forensic Medicine 375
- Genetics 214
Countries citing papers authored by Sarah Hrebien
This map shows the geographic impact of Sarah Hrebien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Hrebien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Hrebien more than expected).
Fields of papers citing papers by Sarah Hrebien
This network shows the impact of papers produced by Sarah Hrebien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Hrebien. The network helps show where Sarah Hrebien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Hrebien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2022 | 2 | |
| 4 | 2020 | 65 | |
| 5 | 2019 | 2 | |
| 6 | 2019 | 71 | |
| 7 | 2019 | 100 | |
| 8 | The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trialbreakdown → | 2018 | 401 |
| 9 | 2018 | 293 | |
| 10 | 2018 | 13 | |
| 11 | 2017 | 118 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 27 | |
| 16 | 2016 | 14 | |
| 17 | 2015 | 1 | |
| 18 | Mutation tracking in circulating tumor DNA predicts relapse in early breast cancerbreakdown → | 2015 | 814 |
| 19 | Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancerbreakdown → | 2015 | 416 |
| 20 | 2014 | 6 |
About Sarah Hrebien
Sarah Hrebien is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 27 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Advanced Breast Cancer Therapies (9 papers), Genetic factors in colorectal cancer (7 papers), Lung Cancer Research Studies (6 papers), Cancer Cells and Metastasis (6 papers), Molecular Biology Techniques and Applications (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.6k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Sarah Hrebien has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nicholas C. Turner, Isaac García-Murillas, Rosalind Cutts, Ben O’Leary, Mitch Dowsett, Massimo Cristofanilli, Cynthia Huang Bartlett, Gaia Schiavon, Iwanka Kozarewa and Ian E. Smith. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.